Patents by Inventor Russell Bialecki

Russell Bialecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7368461
    Abstract: NK2R binding compounds in accord with structural diagram I useful for the treatment or prevention of OAB or UI in mammals, particularly humans are disclosed: wherein in said compounds D, A, R1, R3 and R4 are as defined in the specification. Pharmaceutically-advantageous salts of the compounds, methods of use of the compounds, either alone or in combination with other pharmacological agents, and pharmaceutical compositions useful in practicing the methods of the invention are also disclosed.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: May 6, 2008
    Assignee: AstraZeneca AB
    Inventors: Russell Bialecki, Cathy Dantzman, Keith Herzog
  • Publication number: 20050203113
    Abstract: NK2R binding compounds in accord with structural diagram I useful for the treatment or prevention of OAB or UI in mammals, particularly humans are disclosed: wherein in said compounds D, A, R1, R3 and R4 are as defined in the specification. Pharmaceutically-advantageous salts of the compounds, methods of use of the compounds, either alone or in combination with other pharmacological agents, and pharmaceutical compositions useful in practicing the methods of the invention are also disclosed.
    Type: Application
    Filed: November 1, 2002
    Publication date: September 15, 2005
    Inventors: Russell Bialecki, Cathy Dantzman, Keith Herzog
  • Publication number: 20040248914
    Abstract: Treatment or prevention of OAB or UI in mammals, particularly humans, is disclosed using NK2R binding compounds in accord with structural diagram I: 1
    Type: Application
    Filed: April 30, 2004
    Publication date: December 9, 2004
    Inventors: Russell Bialecki, Cathy Dantzman, Keith Herzog